because the wistar ra27/3 strain rubella virus vaccine has potentially important advantages over rubella vaccines currently licensed in the united states , a field trial was conducted in minnesota and wisconsin in 1974 to evaluate ra27/3 in this country .
C0041703
united states
C0043193
wisconsin